FR2598914B1 - Composition prophylactique et curative pour l'arteriosclerose - Google Patents

Composition prophylactique et curative pour l'arteriosclerose

Info

Publication number
FR2598914B1
FR2598914B1 FR878707258A FR8707258A FR2598914B1 FR 2598914 B1 FR2598914 B1 FR 2598914B1 FR 878707258 A FR878707258 A FR 878707258A FR 8707258 A FR8707258 A FR 8707258A FR 2598914 B1 FR2598914 B1 FR 2598914B1
Authority
FR
France
Prior art keywords
arteriosclerosis
prophylactic
curative composition
acceptable salt
curing composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR878707258A
Other languages
English (en)
Other versions
FR2598914A1 (fr
Inventor
Iwasaki Hitoshi
Kitamura Kazuyuki
Ohtani Akio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Publication of FR2598914A1 publication Critical patent/FR2598914A1/fr
Application granted granted Critical
Publication of FR2598914B1 publication Critical patent/FR2598914B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR878707258A 1986-05-23 1987-05-22 Composition prophylactique et curative pour l'arteriosclerose Expired - Fee Related FR2598914B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11992886 1986-05-23

Publications (2)

Publication Number Publication Date
FR2598914A1 FR2598914A1 (fr) 1987-11-27
FR2598914B1 true FR2598914B1 (fr) 1991-10-25

Family

ID=14773638

Family Applications (1)

Application Number Title Priority Date Filing Date
FR878707258A Expired - Fee Related FR2598914B1 (fr) 1986-05-23 1987-05-22 Composition prophylactique et curative pour l'arteriosclerose

Country Status (10)

Country Link
US (1) US4786634A (fr)
EP (1) EP0250814B1 (fr)
JP (1) JPS63107925A (fr)
AT (2) ATE79259T1 (fr)
DE (1) DE3781044T2 (fr)
DK (1) DK263787A (fr)
FR (1) FR2598914B1 (fr)
GB (1) GB2190587B (fr)
HK (1) HK62292A (fr)
SG (1) SG60092G (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4018018A1 (de) * 1990-06-05 1991-12-12 Schindler Wolfgang Cd-plattengeraet
JP2658783B2 (ja) * 1992-12-10 1997-09-30 田辺製薬株式会社 抗動脈硬化剤

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59157021A (ja) * 1983-02-25 1984-09-06 Tanabe Seiyaku Co Ltd 動脈硬化症予防治療剤
GB8315364D0 (en) * 1983-06-03 1983-07-06 Tanabe Seiyaku Co 8-chloro-1 5-benzothiazepine derivatives
US4567175A (en) * 1983-06-03 1986-01-28 Tanabe Seiyaku Co., Ltd. 8-Chloro-1,5-benzothiazepine derivatives
JPS59231018A (ja) * 1983-06-10 1984-12-25 Tanabe Seiyaku Co Ltd 抗脂血剤
US4585768A (en) * 1984-04-10 1986-04-29 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivatives and processes for preparing the same
JPS60258118A (ja) * 1984-06-06 1985-12-20 Kowa Co 抗動脈硬化剤
US4778791A (en) * 1986-05-16 1988-10-18 Tanabe Seiyaku Co., Ltd. Pharmaceutical composition for improving constitution of lipids in blood

Also Published As

Publication number Publication date
HK62292A (en) 1992-08-28
DK263787D0 (da) 1987-05-22
ATE79259T1 (de) 1992-08-15
EP0250814A3 (en) 1990-01-31
AT390880B (de) 1990-07-10
FR2598914A1 (fr) 1987-11-27
JPS63107925A (ja) 1988-05-12
EP0250814B1 (fr) 1992-08-12
DE3781044D1 (de) 1992-09-17
EP0250814A2 (fr) 1988-01-07
GB2190587A (en) 1987-11-25
GB8711752D0 (en) 1987-06-24
JPH0573728B2 (fr) 1993-10-15
SG60092G (en) 1992-09-04
DE3781044T2 (de) 1993-01-28
GB2190587B (en) 1990-01-17
US4786634A (en) 1988-11-22
DK263787A (da) 1987-11-24
ATA262787A (de) 1990-01-15

Similar Documents

Publication Publication Date Title
EP0256503A3 (en) Pyridinecarboxamide derivatives and their use as fungicide
MX9306831A (es) Nuevos compuestos heterociclicos.
NZ214156A (en) Quindone derivatives and pharmaceutical compositions
DK0408044T3 (da) Antiinflammatorisk og/eller antiallergisk præparat, der omfatter glutathionderivater
ES2046641T3 (es) Composicion antitumoral.
ES2035915T3 (es) Agentes antiarritmicos n-fenetil-aminoalquil-benzamida.
DK0420224T3 (da) Anthihepatopatisk middel
FR2598914B1 (fr) Composition prophylactique et curative pour l'arteriosclerose
TW275629B (fr)
DK644487D0 (da) Farmaceutisk praeparat indeholdende en 2-oxo-imidazolidinforbindelse
ES2060086T3 (es) Derivados de tioformamida.
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
EP0450232A3 (en) P-guanidino benzoic acid derivatives for treatment of cerebrovascular contraction

Legal Events

Date Code Title Description
CA Change of address
ST Notification of lapse